期刊文献+

大鼠肺部与外周血清阿奇霉素浓度对肺炎链球菌抑菌作用的比较 被引量:2

Comparative Effects of Azithromycin in Lung and Peripheral Blood Serum of Rats Against Streptococcus Pneumoniae
下载PDF
导出
摘要 目的观察阿奇霉素在血清、支气管肺泡上皮表面液(ELF)、肺组织匀浆的浓度及随时间分布的特点,并进一步比较三者浓度对肺炎链球菌的抑制作用。方法为SD大鼠灌胃阿奇霉素后微生物法测血、支气管肺泡灌洗液及肺组织匀浆阿奇霉素浓度。ELF的阿奇霉素浓度按尿素稀释法算出。用肉汤微量稀释法测定阿奇霉素、青霉素对27株肺炎链球菌的最低抑菌浓度(MIC),比较血清、ELF和肺组织匀浆阿奇霉素浓度对肺炎链球菌的抑制作用。结果血清、ELF和肺组织匀浆中阿奇霉素浓度在首次给药后51 h最高,分别为(0.652 7±0.213 3),(1.325 5±0.280 3)和(29.094 2±2.940 2)mg.L-1。青霉素对27株肺炎链球菌的敏感率为66.7%,高于阿奇霉素敏感率(14.8%);其中对阿奇霉素耐药的23株肺炎链球菌(85.2%)中,MIC>512 mg.L-1的有16株(69.6%);除去美国疾病控制中心(CDC)的4株肺炎链球菌,仅有30.4%的菌株可被肺组织的峰浓度抑制,8.7%(2/23)可被ELF和血清的阿奇霉素浓度抑制。结论虽然阿奇霉素具有很高的肺组织浓度,并且超过了阿奇霉素中介或低度耐药的肺炎链球菌的MIC水平,但不能单以血清浓度预测阿奇霉素对病原体的抗菌效果。 OBJECTIVE To investigate azithromycin concentrations and time courses in serum, epithelial lining fluid(ELF)and lung homogenate after the administration of azithromycin for rats and then compare their inhibitory effects on Streptococcus pneumoniae. METHODS Azithromycin was given to SD rats through an esophageal catheter. Azithromycin levels in serum, bronchoalveolar lavage fluid and lung homogenate were determined by an agar well diffusion bioassay technique. The concentration of azithromycln in ELF determined by means of the urea dilution method. The minimal inhibitory concentrations(MIC)of azithromycin and penicillin for the 27 strains of Streptococcus pneumoniae were detemined by the broth microdilution method. Then the inhibitory effects of azthromycin in serum, ELF, and lung homogenate on Streptococcus pneumoniae were compared. RESULTS With the employed sampling schedule, the azithromycin concentrations in serum, ELF and lung homogenate were all highest 51 h after the initial dose and declined thereafter, which were (0. 652 7 ± 0. 213 3), (1.325 5 ± 0. 280 3) and (29. 094 2 ± 2.940 2) mg· L^-1, respectively. The susceptibal rate of penicillin to 27 isolates of Streptococcus pneumoniae was 66.7%, which was higher than that of azithromycin (14.8%). Among 23 strains (85.2%) which were resistant to azithromycin, 16 isolates were MIC 〉 512 mg· L^-1(69.6%). Except for 4 strains provided by American Center of Diseases Control(CDC), only 30.4% isolates were inhibited by the azithromycin peak concentration in lung homogenate. While the inhibitation rate of Streptococcus pneumoniae strains in ELF and peripheral blood serum concentrations was 8.7%. CONCLUSION Even though azithromycin concentration in lung is higher than intermidiea or low grade resistant Streptococcus pneumoniae strains, we shouldn't predict the potential efficacy of azithromycin in serum on pathogens.
出处 《中国药学杂志》 CAS CSCD 北大核心 2006年第6期475-478,共4页 Chinese Pharmaceutical Journal
关键词 阿奇霉素 肺炎链球菌 lung azithromycin streptococcus pneumoniae
  • 相关文献

参考文献11

  • 1RETSEMA J A,GIRARD A E,GIRARD D,et al.Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo[J].J Antimicrob Chemother,1990,25(Suppl A):83-89. 被引量:1
  • 2RENNARD S I,BASSET G,LECOSSIER D,et al.Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution[J].J Appl Physiol,1986,60:532-538. 被引量:1
  • 3NISHJIUMA T,SAITO Y,AOKI A,et al.Distribution of mefA and ermB genes in macrolide resistant strains for Streptococcus pneumoniae and their variable susceptibility to various antibiotics[J].J Antimicrob Chemother,1999,43:637-643. 被引量:1
  • 4KHAIR O A,ANDREWS J M,HONEYBOUME D,et al.Lung concentrations of telithromycin after oral dosing[J].J Antimicrob Chemother,2001,47:837-840. 被引量:1
  • 5OLSEN K M,SAN PEDRO G,GANN L P.Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses[J].Antimicrob Agents Chemother,1996,40:2582-2585. 被引量:1
  • 6JANOSI L,NAKAJIMA Y,HASHIMOTO H.Characterization of plasmids that confer inducible resistance to 14-membered macrolides and streptogramin type B antibiotics in Staphylococcus aureus[J].Microbiol Immunol,1990,34:723-735. 被引量:1
  • 7MCDOUGAL L K,TENOVER F C,LEE L N.Detection of Tn917-like sequences within a Tn916-like conjugative transposon (Tn3872)in erythromycin-resistant isolates of Streptococcus pneumoniae[J].Antimicrob Agents Chemother,1998,42:2312-2318. 被引量:1
  • 8JOSEPH P,LYNCH Ⅲ,FEMANDO J,et al.Clinical relevance of macrolide-resistant streptococcus pneumoniae for community-acquired pneumonia[J].Clin Infect Dis,2002,34:S27-S46. 被引量:1
  • 9FELMINGHAM D,WASHINGTON J.Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens-findings of the Alexander Project 1992-1996[J].J Chemother,1999,11:5-21. 被引量:1
  • 10SAHM D F,JONES M E,HICKEY M L,et al.Resistance surveillance of Streptococcus pneumoniae,Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe,1997 ~ 1998[J].J Antimicrob Chemother,2000,45:457-466. 被引量:1

同被引文献12

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部